MELISSA RAY: Open Payments
NPI 1508370867 · MITCHELL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 52 payments from 16 companies in 2025. Trend: 2023 $362 · 2024 $373 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $161 |
| Otsuka America Pharmaceutical, Inc. | 7 | $115 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| Novo Nordisk Inc | 3 | $52 |
| PFIZER INC. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Tris Pharma Inc | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Exact Sciences Corporation | 2 | $33 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, NURTEC ODT, VOQUEZNA, UBRELVY, Dyanavel XR.
Industry payments across IN — which companies pay providers there.
